Logo

Tissue Bank Company Asterand Closes Series C

Nov 21, 2003

NEW YORK, Nov. 21 (GenomeWeb News) - Asterand, which runs a human tissue research bank that supplies genomics and proteomics researchers, said today it has closed a Series C round of funding, but did not disclose the amount of funds raised.

 

The company, based in Detroit, raised the funds from Apjohn Ventures in Ann Arbor, Mich., and Chrysalis Ventures of Louisville, KY, as well as existing investors Oxford Bioscience and Fort Washington Capital Partners.

 

Asterand was founded in 2000 by Randal Charlton, its current CEO, and Alan Walton, general partner at Oxford Bioscience partners. It collects material that covers over 150 diseases, including diabetes, cancer, cardiovascular disease, rheumatoid arthritis and Alzheimer's, schizophrenia, and biopolar disorder.

Breaking News
The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.